These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27708919)

  • 21. Typical and severe tumor necrosis factor receptor-associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series.
    Cantarini L; Lucherini OM; Cimaz R; Rigante D; Baldari CT; Laghi Pasini F; Galeazzi M
    Rheumatol Int; 2012 Dec; 32(12):4015-8. PubMed ID: 20473499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in Japan: a review of the literature.
    Washio M; Nakano T; Kawaguchi Y; Takagi K; Kiyohara C; Tsukamoto H; Tokunaga S; Horiuchi T
    Mod Rheumatol; 2013 Mar; 23(2):210-7. PubMed ID: 22918594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trapped without a diagnosis: Tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Kirresh A; Everitt A; Kon OM; DasGupta R; Pickering MC; Lachmann HJ
    Pract Neurol; 2016 Aug; 16(4):304-7. PubMed ID: 26965498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hereditary periodic fever].
    Lamprecht P; Timmann C; Ahmadi-Simab K; Gross WL
    Internist (Berl); 2004 Aug; 45(8):904-11. PubMed ID: 15243709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
    Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
    Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
    Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers.
    Aksentijevich I; Galon J; Soares M; Mansfield E; Hull K; Oh HH; Goldbach-Mansky R; Dean J; Athreya B; Reginato AJ; Henrickson M; Pons-Estel B; O'Shea JJ; Kastner DL
    Am J Hum Genet; 2001 Aug; 69(2):301-14. PubMed ID: 11443543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Management of a Young Girl With Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS) Linked to a Novel Mutation.
    Klinaki E; Nezos A; Tzioufas AG; Tsolia MN; Maritsi DN
    Cureus; 2020 Oct; 12(10):e10766. PubMed ID: 33154839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Canakinumab for the treatment of TNF-receptor associated periodic syndrome.
    La Torre F; Caparello MC; Cimaz R
    Expert Rev Clin Immunol; 2017 Jun; 13(6):513-523. PubMed ID: 28454496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
    Camprubí D; Mitjavila F; Arostegui JI; Corbella X
    Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients.
    Drewe E; McDermott EM; Powell PT; Isaacs JD; Powell RJ
    Rheumatology (Oxford); 2003 Feb; 42(2):235-9. PubMed ID: 12595616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
    Radhakrishna SM; Grimm A; Broderick L
    BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept.
    Kusuhara K; Hoshina T; Saito M; Ishimura M; Inoue H; Horiuchi T; Sato T; Hara T
    Pediatr Int; 2012 Aug; 54(4):552-5. PubMed ID: 22830546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis.
    Manki A; Nishikomori R; Nakata-Hizume M; Kunitomi T; Takei S; Urakami T; Morishima T
    Allergol Int; 2006 Sep; 55(3):337-41. PubMed ID: 17075277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor receptor-associated periodic syndrome: a novel syndrome with cutaneous manifestations.
    Toro JR; Aksentijevich I; Hull K; Dean J; Kastner DL
    Arch Dermatol; 2000 Dec; 136(12):1487-94. PubMed ID: 11115159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.